Plenary Lecture: Biofuels and Global Climate Change
The official opening session and Plenary Lecture featured a talk from Jerald L. Schnoor, of the University of Iowa, entitled, ?Biofuels and Global Climate Change.? This topic was especially fitting for the June conference as gas prices and temperatures are on the rise once again this summer.
The official opening session and Plenary Lecture featured a talk from Jerald L. Schnoor, of the University of Iowa, entitled, “Biofuels and Global Climate Change.” This topic was especially fitting for the June conference as gas prices and temperatures are on the rise once again this summer.
Jerald L. Schnoor received the B.S. degree in chemical engineering from Iowa State, the M.S. degree in environmental health engineering, from the University of Texas, and the Ph.D. degree in civil engineering from the University of Texas. Throughout his career, Schnoor has been very active in environmental issues. He testified several times before Congress on the environmental effects of acid deposition and the importance of passing the 1990 Clean Air Act. As Editor-in-Chief of Environmental Science and Technology, Schnoor guided the leading journal in the world in both environmental engineering and environmental science. Professor Schnoor has published (as author, co-author, or editor) six books and over 150 research articles in archival journals, in addition to serving as lead editor of a series of texts and monographs for John Wiley & Sons. His vast array of knowledge and his passion for environmental issues was evident in his lecture. Professor Schnoor was an eloquent speaker and surely set the bar high for the rest of the week with his thought-provoking presentation.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
